5-YEAR FOLLOW-UP RESULTS OF THE HERAKLES STUDY: SUPERIOR RENAL FUNCTION AFTER EARLY CONVERSION TO AN EVEROLIMUS-BASED CALCINEURIN INHIBITOR FREE REGIMEN

被引：0
|
作者：
Lehner, F. [1 ]
Guba, M. [1 ]
Sommerer, C. [1 ]
Stahl, R. [1 ]
Vogt, B. [2 ]
Hauser, I. [1 ]
Reinke, P. [1 ]
Jacobi, J. [1 ]
Weithofer, P. [1 ]
Rath, T. [1 ]
Junge, M. [3 ]
Arns, W. [1 ]
Budde, K. [1 ]
Witzke, O. [1 ]
机构：
[1] Herakles Study Grp, Berlin, Germany
[2] Herakles Study Grp, Basel, Switzerland
[3] Novartis Pharma GmbH, Nurnberg, Germany
来源：
TRANSPLANT INTERNATIONAL | 2016年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
P022
引用
收藏
页码：35 / 35
页数：1
相关论文
共 50 条
  • [1] 5 year follow-up results of the HERAKLES study: superior renal function after early conversion to an everolimus-based calcineurin inhibitor free regimen.
    Sommerer, Claudia
    Budde, Klemens
    Arns, Wolfgang
    Reinke, Petra
    Guba, Markus
    Weithofer, Peter
    Vogt, Bruno
    Jacobi, Johannes
    Stahl, Rolf
    Rath, Thomas
    Hauser, Ingeborg A.
    Porstner, Martina
    May, Christoph
    Lehner, Frank
    Witzke, Oliver
    [J]. TRANSPLANTATION, 2016, 100 (07) : S724 - S724
  • [2] Superior Renal Function in an Everolimus-Based Calcineurin Inhibitor Free Regimen Compared to Standard Cyclosporine/Mycophenolate and Low Cyclosporine/Everolimus: Follow-Up of the HERAKLES Study at Month 24
    Budde, K.
    Arns, W.
    Sommerer, C.
    Lehner, F.
    Zeier, M.
    Neumayer, H.
    Guba, M.
    Jacobi, J.
    Weithofer, P.
    May, C.
    Baeumer, D.
    Paulus, E.
    Witzke, O.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 310 - 311
  • [3] Superior Renal Function in an Everolimus-Based Calcineurin Inhibitor Free Regimen Compared to Standard Cyclosporine/Mycophenolate and Low Cyclosporine/Everolimus: Follow-Up of the HERAKLES Study at Month 36
    Budde, K.
    Arns, W.
    Sommerer, C.
    Lehner, F.
    Zeier, M.
    Neumayer, H.
    Guba, M.
    Jacobi, J.
    Weithofer, P.
    Baeumer, D.
    Sieder, C.
    Paulus, E.
    Witzke, O.
    [J]. TRANSPLANTATION, 2014, 98 : 81 - 81
  • [4] SUPERIOR RENAL FUNCTION IN AN EVEROLIMUS-BASED CALCINEURIN INHIBITOR FREE REGIMEN COMPARED TO STANDARD CYCLOSPORINE/MYCOPHENOLATE AND REDUCED CYCLOSPORINE/EVEROLIMUS: FOLLOW-UP OF THE HERAKLES STUDY AT MONTH 48
    Witzke, O.
    Rath, T.
    Weithofer, P.
    Guba, M.
    Jacobi, J.
    Hauser, I. A.
    Vogt, B.
    Stahl, R.
    Porstner, M.
    Reinke, P.
    Zeier, M.
    Lehner, F.
    Arns, W.
    Budde, K.
    Sommerer, C.
    [J]. TRANSPLANT INTERNATIONAL, 2015, 28 : 23 - 23
  • [5] Superior Renal Function in an Everolimus-Based Calcineurin Inhibitor Free Regimen Compared to Standard Cyclosporine/Mycophenolate and Low Cyclosporine/Everolimus: Follow-Up of the HERAKLES Study at Month 48
    Budde, K.
    Sommerer, C.
    Weithofer, P.
    Witzke, O.
    Guba, M.
    Jacobi, J.
    Vogt, B.
    Hauser, I.
    Stahl, R.
    Reinke, P.
    Rath, T.
    Baeumer, D.
    Porstner, M.
    Zeier, M.
    Lehner, F.
    Arns, W.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [6] SUPERIOR RENAL FUNCTION IN AN EVEROLIMUS-BASED CALCINEURIN INHIBITOR FREE REGIMEN COMPARED TO STANDARD CYCLOSPORINE/MYCOPHENOLATE AND LOW CYCLOSPORINE/EVEROLIMUS: FOLLOW-UP OF THE HERAKLES STUDY AT MONTH 36
    Guba, M.
    Budde, K.
    Sommerer, C.
    Neumayer, H. -H.
    Lehner, F.
    Reinke, P.
    Hauser, I. A.
    Weithofer, P.
    Rath, T.
    Baeumer, D.
    Porstner, M.
    Jacobi, J.
    Zeier, M.
    Witzke, O.
    Arns, W.
    [J]. TRANSPLANT INTERNATIONAL, 2014, 27 : 22 - 22
  • [7] Superior Renal Function in an Everolimus-Based Calcineurin Inhibitor Free Regimen Compared to Standard Cyclosporine/Mycophenolate and Low Cyclosporine/Everolimus: Follow-Up of the HERAKLES Study at Month 36.
    Budde, K.
    Arns, W.
    Sommerer, C.
    Lehner, F.
    Zeier, M.
    Neumayer, H.
    Guba, M.
    Jacobi, J.
    Weithofer, P.
    Baeumer, D.
    Sieder, C.
    Paulus, E.
    Witzke, O.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 81 - 81
  • [8] Superior Renal Function in an Everolimus-Based Calcineurin Inhibitor Free Regimen Compared to Standard Cyclosporine/Mycophenolate and Low Cyclosporine/Everolimus: The HERAKLES Study
    Witzke, O.
    Budde, K.
    Lehner, F.
    Zeier, M.
    Neumayer, H. H.
    Stangl, M.
    Jacobi, J.
    Weithofer, P.
    May, C.
    Paulus, E. -M
    Arns, W.
    Sommerer, C.
    [J]. TRANSPLANTATION, 2012, 94 (10) : 993 - 993
  • [9] Superior Renal Function in an Everolimus-Based Calcineurin Inhibitor Free Regimen Compared to Standard Cyclosporine/Mycophenolate and Low Cyclosporine/Everolimus: The HERAKLES Study
    Budde, K.
    Witzke, O.
    Lehner, F.
    Zeier, M.
    Neumayer, H. -H.
    Stangl, M.
    Jacobi, J.
    Kliem, V.
    May, C.
    Paulus, E. -M.
    Arns, W.
    Sommerer, C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 41 - 41
  • [10] 5-YEAR FOLLOW-UP RESULTS OF THE PROTECT LIVER TRANSPLANTATION STUDY: EVEROLIMUS AND EARLY CALCINEURIN INHIBITOR WITHDRAWAL IS ASSOCIATED WITH SUPERIOR RENAL FUNCTION
    Sterneck, M.
    Kaiser, G.
    Heyne, N.
    Richter, N.
    Rauchfuss, F.
    Pascher, A.
    Schemmer, P.
    Fischer, L.
    Klein, C. -G.
    Nadalin, S.
    Lehner, F.
    Settmacher, U.
    Gotthardt, D.
    Loss, M.
    Ladenburger, S.
    Wimmer, P.
    Dworak, M.
    Schlitt, H.
    [J]. TRANSPLANT INTERNATIONAL, 2015, 28 : 31 - 31
12345